Search clinical trials for: Lispro Insulin and glargine insulin
Total 3021 results
-
Universidad de GuanajuatoCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
Indonesia UniversityUnknownDiabetes MellitusIndonesia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
Mannkind CorporationTerminatedDiabetes, Type 1United States, Brazil
-
Diabetes Care CenterUnknownDiabetes Mellitus Type 1United States
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Chronic Kidney DiseaseMexico, United States, Hungary, Ukraine, Brazil, Spain, Romania, South Africa, Poland
-
Eli Lilly and CompanyCompletedType 1 Diabetes | Type 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Greece, India, Netherlands, Poland, Puerto Rico
-
Yale UniversityCompletedDiabetes Mellitus, Type I
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type IIUnited States
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR)Completed
-
Eli Lilly and CompanyTerminated
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Russian Federation, Spain, Mexico, Canada, France, Korea, Republic of
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Type 2 Diabetes Treated With InsulinUnited States, Germany, Mexico, Argentina, Puerto Rico, Italy, Spain, India
-
John H. Stroger HospitalEli Lilly and CompanyCompleted
-
SanofiCompletedDiabetes Mellitus, Insulin-DependentUnited States
-
Third Affiliated Hospital, Sun Yat-Sen UniversityGuangdong Provincial Department of Science and TechnologyUnknownDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Taiwan, South Africa, Korea, Republic of, Spain, Brazil, India, Peru, Philippines, United Kingdom, Hong Kong, France, Mexico
-
HealthPartners InstituteSanofi; International Diabetes Center at Park NicolletCompletedHyperglycemiaUnited States
-
Baylor College of MedicineCompletedHyperglycemia | Diabetes MellitusUnited States
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR)Completed
-
Eli Lilly and CompanyCipla Ltd.Not yet recruitingDiabetes Mellitus, Type 2India
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
BiodelCompletedDiabetes MellitusUnited States
-
Sandra SobelCompletedType 2 Diabetes MellitusUnited States
-
SanofiTerminated
-
GlaxoSmithKlinePPDCompletedDiabetes Mellitus, Type 2Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTurkey
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR); University of TorontoCompleted
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Chile, Colombia, Germany, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Turkey
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusChina, Argentina, Mexico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
University of MiamiTerminated
-
SanofiCompletedDiabetes MellitusChina
-
WockhardtWithdrawnBioequivalence in Healthy SubjectsUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentUnknownInsulin-requiring Type 2 Diabetes MellitusGermany